Tty Biopharm
Tty Biopharm
Taipei, Taiwan1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluating the Treatment Outcomes of Tafasitamab in Patients With Relapsed/ Refractory Diffuse Large B-cell Lymphoma: a Real-world Evidence Study | diffuse large B-cell lymphoma | Active, not recruiting | Not stated | 2026-07-16 | NCT07709624 |